To study the effect of repetitive transcranial magnetic stimulation and amitryptilline on migraine headache
- Conditions
- primary headache
- Registration Number
- CTRI/2018/06/014542
- Lead Sponsor
- Dr Jayantee Kalita
- Brief Summary
This study is a randomized parallel group study comparing the efficacy of repetitive transcranial magnetic stimulation(rtms) on migraine/chronic daily headache patients given either alone or in combination with amitryptilline. One group of patients will receive high frequency rtms on daily basis for 3 days for 3 consecutive months.The second group will be given rtms on similar protocol and will also be additionaly given upto 50 mg of amitryptilline. Patient will also be subjected to hearing threshold, brainstem evoked potential and visual evoked potential during the course of treatment. The primary outcome shall be to reduction of frequency and severity of headache in the two group of patients at 1 2 and 3 months. the secondary outcome shall be the effect of treatment on hearing threshold, brainstem evoked potential and visual evoked potential.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 100
primary headache-migraine and chronic daily headache.
- All patients having any neurological morbidity due to any hereditary, trauma, seizure disorder, meningitis, arterio-veinous malformation, stroke, infection, dyselectrolytemia and any possible secondary cause of headache shall be excluded.
- Pregnancy, liver or kidney failure, malignancy, uncontrolled diabetis and hypertension or headache with underlying psychiatric illness shall be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary out come will be defined as 50% decreases in severity and frequency of headache, at each follow-up visit 1 2 and 3 months
- Secondary Outcome Measures
Name Time Method Effects on habituation viz hearing threshold and brainstem evoked potentials and visual evoked potentials, 1 2 and 3 months
Trial Locations
- Locations (1)
SGPGIMS Lucknow
🇮🇳Lucknow, UTTAR PRADESH, India
SGPGIMS Lucknow🇮🇳Lucknow, UTTAR PRADESH, IndiaDr Jayantee KalitaPrincipal investigator8004904630jayanteek@yahoo.com